Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of the Efficacy of Two Different Suprascapular Nerve Block Techniques in Patients With Chronic Shoulder Pain

NCT04938037

Chronic Shoulder Pain

COMPLETED NA

Comparison Suprascapular Nerve Block and Subacromial Injection in Hemiplegic Shoulder Pain

NCT04433377

Hemiplegia Pain

COMPLETED NA

Ultrasound-Guided Extrafascial Versus Intrafascial Interscalene Brachial Plexus Block in Shoulder Arthroscopy

NCT05222334

Arthroscopy Analgesia Intrafascial Interscalene Brachial Plexus Block

UNKNOWN NA

is There an Alternative to Ultrasound Guided Interscalene Block?

NCT02397330

Regional Anesthesia Interscalene Block Shoulder Surgery

UNKNOWN NA

Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block

NCT01877330

Shoulder Arthroscopy Ultrasound-guided Interscalene Nerve Block

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder Impingement Ultrasound Guided Injection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

prospective,randomized controlled, single blind

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

The patients were followed up and questioned by the evaluator, who was blind to the type of injection administered to the patient.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

subacromial injection

ultrasound (US)-guided subacromial injection

Group Type ACTIVE_COMPARATOR

bupivacaine and methylprednisolone

Intervention Type DRUG

5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area

acromioclavicular joint and subacromial injection

ultrasound (US)-guided acromioclavicular joint and subacromial injection

Group Type ACTIVE_COMPARATOR

bupivacaine and methylprednisolone

Intervention Type DRUG

5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint

suprascapular nerve block

ultrasound (US)-guided suprascapular nerve block

Group Type ACTIVE_COMPARATOR

bupivacaine and methylprednisolone

Intervention Type DRUG

suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bupivacaine and methylprednisolone

5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area

Intervention Type DRUG

bupivacaine and methylprednisolone

5 mL of 0.25% bupivacaine containing 20 mg methylprednisolone was administered to the subacromial area for the subacromial+acromioclavicular joint injection. In addition, 2 mL of 20 mg methylprednisolone and the same concentration of local anaesthetic were injected into the acromioclavicular joint

Intervention Type DRUG

bupivacaine and methylprednisolone

suprascapular nerve block was administered with a mixture of 10 mL of 0.25% bupivacaine and 40 mg methylprednisolone

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

suprascapular nerve block

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged 18-65,
* who were suffering from shoulder pain for more than three months and
* who were diagnosed with IS.
* All patients included in the study were diagnosed with IS using Shoulder Magnetic Resonance imaging.

Exclusion Criteria

* the presence of cervical radiculopathy;
* undergoing shoulder operation before;
* the presence of central nervous system or
* the presence of rheumatological disease, and polyneuropathy;
* receiving physical therapy in the shoulder area with a diagnosis of IS within the last six months; and
* receiving any injection therapy in the past.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No